Insider · CIK 0001274139

HERSHBERG ROBERT

Reports to the SEC for 9 companies · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001274139

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	Director	SSale	−25K sh	$5.00	−$125K	162,156
2026-10-06	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	$2.22	−$55.5K	500,000
2026-10-06	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$2.22	+$55.5K	187,156
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−122K sh	—	—	0
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−62.4K sh	—	—	0
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−103K sh	—	—	0
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−405K sh	—	—	0
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−48.9K sh	—	—	0
2026-08-18	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2026-08-18	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−15K sh	$24.39	−$366K	62,347
2026-08-18	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−15.7K sh	$24.41	−$382K	46,683
2026-08-18	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$6.32	+$94.8K	77,347
2026-07-07	ATAIAtaiBeckley Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−51.1K sh	—	—	404,869
2026-07-07	ATAIAtaiBeckley Inc. · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−48.9K sh	—	—	48,858
2026-07-07	ATAIAtaiBeckley Inc.S Sale	Director	SSale	−100K sh	$4.96	−$496K	100,000
2026-07-07	ATAIAtaiBeckley Inc.M Exercise/Conversion	Director	MExercise/Conversion	+48.9K sh	$1.35	+$66K	48,858
2026-07-07	ATAIAtaiBeckley Inc.M Exercise/Conversion	Director	MExercise/Conversion	+51.1K sh	$1.35	+$69K	100,000
2026-06-17	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+88.4K sh	—	—	162,156
2026-06-04	ATAIAtaiBeckley Inc. · Stock OptionA Award	Director	AAward	+122K sh	—	—	121,968
2026-03-04	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+15.6K sh	—	—	62,347
2025-12-10	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−23K sh	$16.00	−$367K	46,722
2025-11-05	ATAIAtai Beckley N.V. · Stock OptionA Award	Director	AAward	+103K sh	—	—	103,000
2025-11-05	ATAIAtai Beckley N.V. · Stock OptionA Award	Director	AAward	+97.7K sh	—	—	97,716
2025-11-05	ATAIAtai Beckley N.V. · Stock OptionA Award	Director	AAward	+62.4K sh	—	—	62,394
2025-11-05	ATAIAtai Beckley N.V. · Stock OptionA Award	Director	AAward	+456K sh	—	—	456,011
2025-09-17	HilleVax, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−1.1M sh	—	—	0
2025-06-18	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+22K sh	—	—	73,732
2025-06-18	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+44K sh	—	—	44,031
2025-03-12	ADPTAdaptive Biotechnologies CorpS Sale	Director	SSale	−53K sh	$7.59	−$402K	69,690
2025-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Director	AAward	+23.7K sh	—	—	23,726
2025-03-04	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+15.4K sh	—	—	122,690
2025-02-11	HilleVax, Inc.S Sale	Director, President and CEO	SSale	−11.9K sh	$1.76	−$21K	1,101,498
2025-02-04	HilleVax, Inc.S Sale	Director, President and CEO	SSale	−14.6K sh	$1.89	−$27.7K	1,113,399
2024-06-03	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+26.2K sh	—	—	26,193
2024-06-03	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+13.1K sh	—	—	51,716
2024-03-04	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Director	AAward	+48K sh	—	—	48,044
2024-03-04	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+31.3K sh	—	—	107,296
2024-02-08	HilleVax, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+227K sh	—	—	226,885
2024-02-08	HilleVax, Inc.A Award	Director, President and CEO	AAward	+174K sh	—	—	1,128,033
2024-02-08	HilleVax, Inc.S Sale	Director, President and CEO	SSale	−11.6K sh	$14.93	−$173K	953,831
2023-06-16	RXRXRECURSION PHARMACEUTICALS, INC.A Award	Director	AAward	+12.6K sh	—	—	38,619
2023-06-16	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+25.2K sh	—	—	25,224
2023-06-06	FATEFATE THERAPEUTICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-03-06	ADPTAdaptive Biotechnologies CorpA Award	Director	AAward	+14.8K sh	—	—	75,968
2023-03-06	ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award	Director	AAward	+23.3K sh	—	—	23,329
2023-02-02	ADPTAdaptive Biotechnologies CorpM Exercise/Conversion	Director	MExercise/Conversion	+53K sh	$0.45	+$23.9K	61,193
2023-02-02	ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−53K sh	—	—	0
2023-02-01	HilleVax, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+382K sh	—	—	381,950
2023-02-01	HilleVax, Inc.A Award	Director, President and CEO	AAward	+188K sh	—	—	965,428
2022-06-14	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+36.3K sh	—	—	36,290

Recent filings

Accepted (ET)
Oct 7 18:084
HERSHBERG ROBERT0001601830-26-000119
SEC(opens sec.gov)
Sep 114
HERSHBERG ROBERT0001140361-26-036379
SEC(opens sec.gov)
Aug 204
HERSHBERG ROBERT0001274139-26-000004
SEC(opens sec.gov)
Jul 94
HERSHBERG ROBERT0001140361-26-028137
SEC(opens sec.gov)
Jun 224
HERSHBERG ROBERT0001601830-26-000087
SEC(opens sec.gov)
Jun 84
HERSHBERG ROBERT0001140361-26-024524
SEC(opens sec.gov)
Mar 64
HERSHBERG ROBERT0001274139-26-000001
SEC(opens sec.gov)

Companies

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101